Find out more about how tirzepatide performed better than semaglutide in weight reduction in a 2026 network meta-analysis.

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...

In today’s fast-paced world, maintaining optimal health and wellness can often feel like a daunting task. With numerous products on the market, finding the right one that aligns with your health goals ...

Oral semaglutide lowers heart failure events in people with type 2 diabetes and existing heart failure without increasing ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Medically reviewed by Danielle Weiss, MD Zepbound (tirzepatide) and Wegovy (semaglutide) are drugs approved by the Food and Drug Administration (FDA) to treat type 2 diabetes as well as obesity and ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review the ...

In weight loss solutions, the search for effective methods without the hassle of needles and prescriptions has become more prevalent than ever. Enter Bionex GLP1 Semaglutide, a revolutionary natural ...

Many semaglutide (e.g., Ozempic) users keep taking the drug because they see real weight loss or appetite reduction.  A Rutgers study analyzed anon ...

Compounded Semaglutide for Weight Loss: Is It Safe & Effective? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Is compounded semaglutide effective for weight loss? Here’s the short ...

A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis ...

Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than previously reported. Using the specific ...